Iamgold Corporation Ordinary Shares vs 22nd Century Group Inc — how do they compare? Iamgold Corporation Ordinary Shares trades at $18.8 (market cap $10.49B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Iamgold Corporation Ordinary Shares is far larger — about 16873.9× 22nd Century Group Inc's market cap, and Iamgold Corporation Ordinary Shares is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iamgold Corporation Ordinary Shares for 1 Days and 22nd Century Group Inc for 32 Days on average.
| IAG | XXII | |
|---|---|---|
Market Cap | $10.49B | $621.67K |
Volume | 3,160,902 | 45,625 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $24.57 | $483.00 |
52-Week Low | $10.96 | $0.80 |
Typical Hold Time | 1 Days | 32 Days |
Enterprise Value | $10.53B | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
IAMGOLD is a gold mining company with operations in Canada. It also explores and develops gold properties.
Read more on IAG →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →